General MedicationsSUBCUTANEOUSGeneric
Rybrevant Faspro
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
Standard Dose
Refer to label-specific dosage instructions.
Max Dose
See product label
Primary Use
Marketed injection containing AMIVANTAMAB, HYALURONIDASE (HUMAN RECOMBINANT).
Summary
Product profile Marketed injection containing AMIVANTAMAB, HYALURONIDASE (HUMAN RECOMBINANT).
Dose form and route INJECTION · SUBCUTANEOUS
Structured Monograph
Clinical summary
Product profile Marketed injection containing AMIVANTAMAB, HYALURONIDASE (HUMAN RECOMBINANT). Dose form and route INJECTION · SUBCUTANEOUS
Monitoring
- • Review the product-specific label before prescribing.
Interaction Notes
- • Interaction data should be confirmed against the corresponding label.